AN1 — Anagenics Income Statement
0.000.00%
Last trade - 00:00
- AU$4.17m
- AU$3.69m
- AU$9.11m
- 14
- 79
- 32
- 39
2019 June 30th | R2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.47 | 7.34 | 5.82 | 6.95 | 9.11 |
Cost of Revenue | |||||
Gross Profit | 5.33 | 4.85 | 3.7 | 3.8 | 4.41 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 14 | 12.5 | 10.3 | 8.78 | 11 |
Operating Profit | -6.53 | -5.11 | -4.52 | -1.84 | -1.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.77 | -4.27 | -3.76 | -1.64 | -1.73 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.79 | -4.36 | -3.8 | -1.64 | -1.74 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -6.79 | -4.91 | -3.39 | -3.65 | -2.67 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.79 | -4.91 | -3.39 | -3.65 | -2.67 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.062 | -0.038 | -0.023 | -0.007 | -0.006 |